Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

Detalles Bibliográficos
Autores principales: Schubert, Maria-Luisa, Bethge, Wolfgang A., Ayuk, Francis A., von Bonin, Malte, Vucinic, Vladan, Wagner-Drouet, Eva Marie, Subklewe, Marion, Baldus, Claudia D., Glass, Bertram, Marks, Reinhard, Mougiakakos, Dimitrios, Schroers, Roland, Stelljes, Matthias, Topp, Max S., Wulf, Gerald, Kröger, Nicolaus, Dreger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582836/
https://www.ncbi.nlm.nih.gov/pubmed/37603595
http://dx.doi.org/10.1182/bloodadvances.2023011203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582836/
https://www.ncbi.nlm.nih.gov/pubmed/37603595
http://dx.doi.org/10.1182/bloodadvances.2023011203

Ejemplares similares